Fliszár-Nyúl, E.; Csepregi, R.; Benkovics, G.; Szente, L.; Poór, M.
Testing the Protective Effects of Sulfobutylether-Βeta-Cyclodextrin (SBECD) and Sugammadex against Chlorpromazine-Induced Acute Toxicity in SH-SY5Y Cell Line and in NMRI Mice. Pharmaceutics 2022, 14, 1888.
https://doi.org/10.3390/pharmaceutics14091888
AMA Style
Fliszár-Nyúl E, Csepregi R, Benkovics G, Szente L, Poór M.
Testing the Protective Effects of Sulfobutylether-Βeta-Cyclodextrin (SBECD) and Sugammadex against Chlorpromazine-Induced Acute Toxicity in SH-SY5Y Cell Line and in NMRI Mice. Pharmaceutics. 2022; 14(9):1888.
https://doi.org/10.3390/pharmaceutics14091888
Chicago/Turabian Style
Fliszár-Nyúl, Eszter, Rita Csepregi, Gábor Benkovics, Lajos Szente, and Miklós Poór.
2022. "Testing the Protective Effects of Sulfobutylether-Βeta-Cyclodextrin (SBECD) and Sugammadex against Chlorpromazine-Induced Acute Toxicity in SH-SY5Y Cell Line and in NMRI Mice" Pharmaceutics 14, no. 9: 1888.
https://doi.org/10.3390/pharmaceutics14091888
APA Style
Fliszár-Nyúl, E., Csepregi, R., Benkovics, G., Szente, L., & Poór, M.
(2022). Testing the Protective Effects of Sulfobutylether-Βeta-Cyclodextrin (SBECD) and Sugammadex against Chlorpromazine-Induced Acute Toxicity in SH-SY5Y Cell Line and in NMRI Mice. Pharmaceutics, 14(9), 1888.
https://doi.org/10.3390/pharmaceutics14091888
